Daniel Karen L 4
4 · Teladoc Health, Inc. · Filed May 24, 2024
Insider Transaction Report
Form 4
Daniel Karen L
Director
Transactions
- Sale
Common Stock
2024-05-23$11.90/sh−9,834$117,025→ 36,995 total - Exercise/Conversion
Common Stock
2024-05-22+9,834→ 46,829 total - Exercise/Conversion
Restricted Stock Units
2024-05-22−9,834→ 0 total→ Common Stock (9,834 underlying)
Footnotes (4)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 15, 2023.
- [F3]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- [F4]On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024.